Rechallenge of everolimus for metastatic renal cell carcinoma after recovery from grade 3 interstitial lung disease : a case report
We report a case of the rechallenge of everolimus for metastatic renal cell carcinoma (RCC) after successful recovery from grade 3 interstitial lung disease (ILD). A 76-year-old man with metastatic RCC developed grade 3 ILD one month after the initiation of everolimus therapy (10 mg/day). ILD subsid...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 60(2014), 1 vom: 26. Jan., Seite 25-8 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
2014
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Case Reports Journal Article Antineoplastic Agents Enzyme Inhibitors Everolimus 9HW64Q8G6G Prednisolone 9PHQ9Y1OLM TOR Serine-Threonine Kinases EC 2.7.11.1 mehr... |
| Zusammenfassung: | We report a case of the rechallenge of everolimus for metastatic renal cell carcinoma (RCC) after successful recovery from grade 3 interstitial lung disease (ILD). A 76-year-old man with metastatic RCC developed grade 3 ILD one month after the initiation of everolimus therapy (10 mg/day). ILD subsided in 4 months after the withdrawal of everolimus and treatment with corticosteroids. Half dose (5 mg/day) of everolimus was rechallenged for 9 months until another grade 3 ILD developed. Everolimus kept the disease under control for 13 months including the discontinuation period |
|---|---|
| Beschreibung: | Date Completed 13.05.2014 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
| ISSN: | 0018-1994 |